Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $3.82 billion. The enterprise value is $3.06 billion.
| Market Cap | 3.82B |
| Enterprise Value | 3.06B |
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 122.38 million shares outstanding. The number of shares has increased by 1.12% in one year.
| Current Share Class | 122.38M |
| Shares Outstanding | 122.38M |
| Shares Change (YoY) | +1.12% |
| Shares Change (QoQ) | -0.41% |
| Owned by Insiders (%) | 5.52% |
| Owned by Institutions (%) | 87.30% |
| Float | 115.58M |
Valuation Ratios
The trailing PE ratio is 18.02 and the forward PE ratio is 16.45. CPRX's PEG ratio is 1.32.
| PE Ratio | 18.02 |
| Forward PE | 16.45 |
| PS Ratio | 6.39 |
| Forward PS | 5.80 |
| PB Ratio | 3.76 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | 18.33 |
| P/OCF Ratio | 18.33 |
| PEG Ratio | 1.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.01, with an EV/FCF ratio of 14.72.
| EV / Earnings | 13.84 |
| EV / Sales | 5.13 |
| EV / EBITDA | 10.01 |
| EV / EBIT | 11.44 |
| EV / FCF | 14.72 |
Financial Position
The company has a current ratio of 7.10, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.10 |
| Quick Ratio | 6.70 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 24.50% and return on invested capital (ROIC) is 78.76%.
| Return on Equity (ROE) | 24.50% |
| Return on Assets (ROA) | 16.27% |
| Return on Invested Capital (ROIC) | 78.76% |
| Return on Capital Employed (ROCE) | 26.36% |
| Weighted Average Cost of Capital (WACC) | 8.19% |
| Revenue Per Employee | $3.28M |
| Profits Per Employee | $1.22M |
| Employee Count | 182 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.48 |
Taxes
In the past 12 months, CPRX has paid $75.14 million in taxes.
| Income Tax | 75.14M |
| Effective Tax Rate | 25.34% |
Stock Price Statistics
The stock price has increased by +33.25% in the last 52 weeks. The beta is 0.72, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +33.25% |
| 50-Day Moving Average | 26.31 |
| 200-Day Moving Average | 23.20 |
| Relative Strength Index (RSI) | 73.38 |
| Average Volume (20 Days) | 3,231,437 |
Short Selling Information
The latest short interest is 7.84 million, so 6.41% of the outstanding shares have been sold short.
| Short Interest | 7.84M |
| Short Previous Month | 8.49M |
| Short % of Shares Out | 6.41% |
| Short % of Float | 6.78% |
| Short Ratio (days to cover) | 4.33 |
Income Statement
In the last 12 months, CPRX had revenue of $596.96 million and earned $221.32 million in profits. Earnings per share was $1.73.
| Revenue | 596.96M |
| Gross Profit | 501.66M |
| Operating Income | 267.64M |
| Pretax Income | 296.46M |
| Net Income | 221.32M |
| EBITDA | 305.83M |
| EBIT | 267.64M |
| Earnings Per Share (EPS) | $1.73 |
Balance Sheet
The company has $755.86 million in cash and $2.68 million in debt, with a net cash position of $753.18 million or $6.15 per share.
| Cash & Cash Equivalents | 755.86M |
| Total Debt | 2.68M |
| Net Cash | 753.18M |
| Net Cash Per Share | $6.15 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 8.29 |
| Working Capital | 807.99M |
Cash Flow
In the last 12 months, operating cash flow was $208.21 million and capital expenditures -$85,000, giving a free cash flow of $208.13 million.
| Operating Cash Flow | 208.21M |
| Capital Expenditures | -85,000 |
| Depreciation & Amortization | 38.19M |
| Net Borrowing | n/a |
| Free Cash Flow | 208.13M |
| FCF Per Share | $1.70 |
Margins
Gross margin is 84.04%, with operating and profit margins of 44.83% and 37.08%.
| Gross Margin | 84.04% |
| Operating Margin | 44.83% |
| Pretax Margin | 49.66% |
| Profit Margin | 37.08% |
| EBITDA Margin | 51.23% |
| EBIT Margin | 44.83% |
| FCF Margin | 34.86% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.12% |
| Shareholder Yield | -1.12% |
| Earnings Yield | 5.80% |
| FCF Yield | 5.45% |
Analyst Forecast
The average price target for CPRX is $31.50, which is 1.03% higher than the current price. The consensus rating is "Hold".
| Price Target | $31.50 |
| Price Target Difference | 1.03% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 6.26% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 15.04 and a Piotroski F-Score of 5.
| Altman Z-Score | 15.04 |
| Piotroski F-Score | 5 |